Moreover, we analyzed the survival of HCC patients with sorafenib treatment and found that patients with low GCN5L1 expression survived longer than those with high GCN5L1 expression (Supplementary Fig. 1E). Here, BLOC1S1 is linked to hepatocellular carcinoma.